Madam Chair, the issue is not whether I agree or disagree with my colleague from eastern Canada. I listen to MS patients who are contacting me and telling me that they want access to this treatment. They know the research needs to go on, but they also think they should have access to the treatment that has proven to be effective.
In the House of Commons on June 14th, 2010. See this statement in context.